Share on StockTwits

Acceleron Pharma (NASDAQ:XLRN) SVP Matthew L. Sherman sold 7,500 shares of Acceleron Pharma stock in a transaction that occurred on Wednesday, July 9th. The shares were sold at an average price of $28.99, for a total value of $217,425.00. Following the completion of the transaction, the senior vice president now directly owns 13,858 shares of the company’s stock, valued at approximately $401,743. The sale was disclosed in a legal filing with the SEC, which is available at this link.

Acceleron Pharma (NASDAQ:XLRN) traded down 0.33% during mid-day trading on Friday, hitting $30.30. 81,551 shares of the company’s stock traded hands. Acceleron Pharma has a 1-year low of $16.78 and a 1-year high of $57.89. The stock has a 50-day moving average of $32.36 and a 200-day moving average of $38.63. The company’s market cap is $953.1 million.

Acceleron Pharma (NASDAQ:XLRN) last issued its quarterly earnings data on Thursday, May 15th. The company reported ($0.30) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.44) by $0.14. The company had revenue of $3.31 million for the quarter, compared to the consensus estimate of $2.85 million. On average, analysts predict that Acceleron Pharma will post $-1.24 earnings per share for the current fiscal year.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.